Diabeloop develops innovative solutions, integrating therapeutic artificial intelligence, to automate the treatment of type 1 diabetes.
Location: France, Auvergne-Rhone-Alpes, Grenoble
Employees: 11-50
Total raised: $75.18M
Founded date: 2011
Investors 1
| Date | Name | Website |
| 10.06.2022 | LBO France | lbofrance.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.06.2022 | - | $75.18M | LBO France |
Mentions in press and media 15
| Date | Title | Description |
| 08.01.2026 | ViCentra secures an additional $13M to accelerate growth and advance next-gen insulin system | Dutch-based medical device company ViCentra, which commercialises the Kaleido insulin patch pump system, has raised an additional $13 million as part of its Series D financing, bringing the total round to $98 million. The funding includes n... |
| 06.09.2025 | ViCentra Secures $85 Million to Revolutionize Diabetes Care with Kaleido Patch Pump, Eyes U.S. Market | ViCentra, a European MedTech firm, raised $85 million in Series D funding. This capital will accelerate production and launch of its Kaleido 2 patch pump across Europe. It also prepares for critical U.S. market entry. Kaleido offers a uniqu... |
| 05.09.2025 | ViCentra: $85 Million Raised To Expand Kaleido Patch Pump And Advance Global Diabetes Care | ViCentra, a European medical technology company focused on transforming insulin delivery for people living with diabetes, has announced the close of an $85 million Series D funding round. The round was led by Innovation Industries and inclu... |
| 05.09.2025 | Dutch MedTech startup ViCentra raises €72.4 million to scale their Kaleido insulin patch pump | ViCentra, an Utrecht-based medical device company innovating insulin delivery for people with diabetes, announced the successful close of a €72.4 million Series D financing to accelerate manufacturing and launch the Kaleido 2 patch pump in ... |
| 16.06.2022 | LBO France leads Diabeloop’s €70m Series C financing round | Press release Paris, June 2nd 2022 |
| 03.06.2022 | This Week in European Tech: Hypercar maker Rimac raises €500 million, Supercell buys Trailmix, Germany plots major 'sovereign tech' fund, and more What happened this week in European Tech? | This week, our research team tracked more than 110 tech funding deals worth over €1.8 billion, and over 15 exits, M&A transactions, and rumours, and related news stories across Europe. As always, we are putting all of them together for ... |
| 03.06.2022 | Diabeloop secures €70M to automate the treatment and management of diabetes; here’s how | Diabeloop, a France-based medical device company that offers AI-based, personalised solutions to automate the treatment and management of diabetes, announced on Thursday that it has raised €70M in its Series C round of funding. The company ... |
| 02.06.2022 | Diabeloop rounds up €70M to take AI-powered insulin delivery tech global | After decades of having to juggle multiple devices and fingerprick systems to take their own blood sugar readings and use them to calculate insulin dosages, people with diabetes now have access to technologies that’ll do virtually all of th... |
| 22.03.2021 | BIOCORP and Diabeloop announce co-development agreement in personalized diabetes management | ISSOIRE, France and GRENOBLE, France and PARIS, March 22, 2021 /PRNewswire/ -- BIOCORP (FR0012788065 - ALCOR / Eligible PEA PME), a French company specialized in the development and manufacturing of medical devices and connected solutions i... |
| 01.03.2021 | Diabeloop integrates the Accu-Chek Insight insulin pump from Roche into its Automated Insulin Delivery System |
Show more